TY - JOUR
T1 - Tethered-liquid omniphobic surface coating reduces surface thrombogenicity, delays clot formation and decreases clot strength ex vivo
AU - Roberts, Teryn R.
AU - Leslie, Daniel C.
AU - Cap, Andrew P.
AU - Cancio, Leopoldo C.
AU - Batchinsky, Andriy I.
N1 - Publisher Copyright:
© 2019 Wiley Periodicals, Inc.
PY - 2020/2/1
Y1 - 2020/2/1
N2 - Hemocompatible materials for extracorporeal life support (ECLS) technology are investigated to mitigate thrombotic complications associated with this therapy. A promising solution is an omniphobic bilayer coating, tethered liquid perfluorocarbon (TLP), which utilizes an immobilized tether to anchor a mobile, liquid surface lubricant that prevents adhesion of blood components to the substrate. In this study, we investigated the effects of TLP on real-time clot formation using thromboelastography (TEG). TLP was applied to TEG cups, utilizing perfluorodecalin (PFD) or FluorLube63 as the liquid layer, and compared to uncoated cups. Human blood (n = 10) was added to cups; and TEG parameters (R, K, α-angle, MA, LY30, LY60) and adherent thrombus weight were assessed. TLP decreased clot amplification (α-angle), clot strength (MA), and adherent clot weight (p <.0001). These effects were greater with FluorLube63 versus PFD (α-angle p <.0001; MA p =.0019; clot weight p <.0001). Reaction time (R) was longer in TLP-coated cups versus control cups with liquid lubricant added (p =.0377). Percent fibrinolysis (LY30 and LY60) was greater in the TLP versus controls at LY30 (p <.0001), and in FluoroLube63 versus controls at LY60 (p =.0021). TLP significantly altered clot formation, exerting antithrombogenic effects. This reduction in surface thrombogenicity supports TLP as a candidate for improved biocompatibility of ECLS materials, pending further validation with exposure to shear stress.
AB - Hemocompatible materials for extracorporeal life support (ECLS) technology are investigated to mitigate thrombotic complications associated with this therapy. A promising solution is an omniphobic bilayer coating, tethered liquid perfluorocarbon (TLP), which utilizes an immobilized tether to anchor a mobile, liquid surface lubricant that prevents adhesion of blood components to the substrate. In this study, we investigated the effects of TLP on real-time clot formation using thromboelastography (TEG). TLP was applied to TEG cups, utilizing perfluorodecalin (PFD) or FluorLube63 as the liquid layer, and compared to uncoated cups. Human blood (n = 10) was added to cups; and TEG parameters (R, K, α-angle, MA, LY30, LY60) and adherent thrombus weight were assessed. TLP decreased clot amplification (α-angle), clot strength (MA), and adherent clot weight (p <.0001). These effects were greater with FluorLube63 versus PFD (α-angle p <.0001; MA p =.0019; clot weight p <.0001). Reaction time (R) was longer in TLP-coated cups versus control cups with liquid lubricant added (p =.0377). Percent fibrinolysis (LY30 and LY60) was greater in the TLP versus controls at LY30 (p <.0001), and in FluoroLube63 versus controls at LY60 (p =.0021). TLP significantly altered clot formation, exerting antithrombogenic effects. This reduction in surface thrombogenicity supports TLP as a candidate for improved biocompatibility of ECLS materials, pending further validation with exposure to shear stress.
KW - anticoagulation
KW - antithrombogenic surface
KW - biocompatibility
KW - biomaterials
UR - http://www.scopus.com/inward/record.url?scp=85065640530&partnerID=8YFLogxK
U2 - 10.1002/jbm.b.34406
DO - 10.1002/jbm.b.34406
M3 - Article
C2 - 31069955
AN - SCOPUS:85065640530
SN - 1552-4973
VL - 108
SP - 496
EP - 502
JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials
JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials
IS - 2
ER -